Philip Perera
2021
In 2021, Philip Perera earned a total compensation of $605.5K as Former Chief Medical Officer at Longboard Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,724 |
|---|---|
| Salary | $423,500 |
| Other | $13,227 |
| Total | $605,451 |
Perera received $423.5K in salary, accounting for 70% of the total pay in 2021.
Perera also received $168.7K in non-equity incentive plan and $13.2K in other compensation.
Rankings
In 2021, Philip Perera's compensation ranked 10,290th out of 12,415 executives tracked by ExecPay. In other words, Perera earned more than 17.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,290 out of 12,415 | 17th |
Division Manufacturing | 4,558 out of 5,505 | 17th |
Major group Chemicals And Allied Products | 2,038 out of 2,375 | 14th |
Industry group Drugs | 1,807 out of 2,096 | 14th |
Industry Pharmaceutical Preparations | 1,341 out of 1,546 | 13th |
Source: SEC filing on April 13, 2022.
Perera's colleagues
We found two more compensation records of executives who worked with Philip Perera at Longboard Pharmaceuticals in 2021.